Folia Cardiologica | 2019
Nowe markery biologiczne w kardiologii — czy to właściwy trop?
Abstract
There are many markers for the risk assessment of cardiovascular diseases. New sensitive and specific biomarkers that could help stratify risk, in both healthy and cardiovascular populations, are still being sought. Galectin 3 and ST-2 seem to be very promising molecules. However, further research is needed to establish their full diagnostic and pro- gnostic value. We present a review of the literature showing the possibility of comprehensive use of both biomarkers, especially in coronary artery disease. Galectin 3 and ST-2, through their association with fibrotic processes, may prove to be beneficial in patients with coronary disease and following myocardial infarction.